Europe — EMA
Co-Dydramol (Dihydrocodeine Tartrate, Paracetamol)
Co-Dydramol is a combination pain relief medication containing Dihydrocodeine Tartrate and Paracetamol. It is commonly used for managing moderate to severe pain
Request sourcing
What is Dihydrocodeine Tartrate, Paracetamol?
Co-Dydramol is a combination pain relief medication containing Dihydrocodeine Tartrate and Paracetamol. It is commonly used for managing moderate to severe pain. This oral medication is manufactured by Bristol Laboratories Limited in the EU.
What is Dihydrocodeine Tartrate, Paracetamol used for?
Co-Dydramol is typically used for pain relief, including conditions like headaches, dental pain, and musculoskeletal discomfort. The combination of Dihydrocodeine Tartrate, an opioid analgesic, and Paracetamol provides a dual-action approach to managing pain. People often ask, 'What is Co-Dydramol used for?' and it is generally prescribed for conditions requiring stronger pain management than paracetamol alone.
What are the side effects of Dihydrocodeine Tartrate, Paracetamol?
Common effects of Co-Dydramol may include drowsiness, dizziness, and nausea. Some users might experience constipation or dry mouth. These effects can vary depending on individual tolerance and dosage. It is important to be aware of how this medication affects you before operating heavy machinery or driving.
What precautions apply to Dihydrocodeine Tartrate, Paracetamol?
Co-Dydramol should be handled with care, especially by individuals with a history of liver disease, respiratory issues, or substance abuse. It is crucial to follow the prescribed dosage and avoid exceeding the recommended intake to prevent potential side effects. Always consult a healthcare professional before starting any new medication.
What does Dihydrocodeine Tartrate, Paracetamol interact with?
Co-Dydramol can interact with various substances, including alcohol, other pain relievers, and certain antidepressants. It is advisable to avoid alcohol while taking this medication, as it can enhance the sedative effects. Additionally, interactions with CYP inhibitors may alter the metabolism of Co-Dydramol, so it is important to inform your healthcare provider about all medications you are taking.



